The reaffirmation of a Buy rating and a high price target by a reputable analyst like Robyn Karnauskas from Truist Securities is likely to instill confidence among investors about Regeneron's stock. This positive outlook could lead to an increase in investor interest and potentially drive up the stock price in the short term.